These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4318447)

  • 1. Hazard from antibiotics in myasthenia gravis.
    McQuillen MP
    Ann Intern Med; 1970 Sep; 73(3):487-8. PubMed ID: 4318447
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug therapy: Disorders of neuromuscular transmission caused by drugs.
    Argov Z; Mastaglia FL
    N Engl J Med; 1979 Aug; 301(8):409-13. PubMed ID: 223053
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of germine acetates on neuromuscular transmission.
    Brennan JL; Jones SF; McLeod JG
    J Neurol Sci; 1971 Jul; 13(3):321-31. PubMed ID: 4330354
    [No Abstract]   [Full Text] [Related]  

  • 4. Corticotropin therapy in patients with myasthenia gravis. Electrophysiologic, pharmacologic studies.
    Namba T
    Arch Neurol; 1972 Feb; 26(2):144-50. PubMed ID: 4332732
    [No Abstract]   [Full Text] [Related]  

  • 5. Short-term effects of prednisolone on neuromuscular transmission in normal rats and those with experimental autoimmune myasthenia gravis.
    Kim YI; Goldner MM; Sanders DB
    J Neurol Sci; 1979 Apr; 41(2):223-34. PubMed ID: 220391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse drug effects on neuromuscular transmission.
    Howard JF
    Semin Neurol; 1990 Mar; 10(1):89-102. PubMed ID: 2161128
    [No Abstract]   [Full Text] [Related]  

  • 7. Benefit from alternate-day prednisone in myasthenia gravis.
    Warmolts JR; Engel WK
    N Engl J Med; 1972 Jan; 286(1):17-20. PubMed ID: 4331158
    [No Abstract]   [Full Text] [Related]  

  • 8. Myasthenia gravis.
    Engel WK; Festoff BW; Patten BM; Swerdlow ML; Newball HH; Thompson MD
    Ann Intern Med; 1974 Aug; 81(2):225-46. PubMed ID: 4367701
    [No Abstract]   [Full Text] [Related]  

  • 9. A reassessment of the neurophysiological evidence for a presynaptic defect in myasthenia gravis.
    Bergmans J; Fannes-Breselow CF; Gribomont B
    Electromyogr Clin Neurophysiol; 1976; 16(4):337-51. PubMed ID: 187402
    [No Abstract]   [Full Text] [Related]  

  • 10. The site and mode of action of propanidid on the peripheral motor unit.
    Ellis FR
    Anaesthesist; 1971 Jan; 20(1):19-22. PubMed ID: 4322995
    [No Abstract]   [Full Text] [Related]  

  • 11. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further electrophysiological studies of neuromuscular transmission in an animal model of myasthenia gravis.
    Kim YI; Sanders DB
    Exp Neurol; 1981 Jul; 73(1):1-19. PubMed ID: 6265267
    [No Abstract]   [Full Text] [Related]  

  • 13. Study of long-term anticholinesterase therapy. Effects on neuromuscular transmission and on motor end-plate fine structure.
    Engel AG; Lambert EH; Santa T
    Neurology; 1973 Dec; 23(12):1273-81. PubMed ID: 4357114
    [No Abstract]   [Full Text] [Related]  

  • 14. Myasthenia gravis and atracurium. A case report.
    Macdonald AM; Keen RI; Pugh ND
    Br J Anaesth; 1984 Jun; 56(6):651-4. PubMed ID: 6326789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's disease and myasthenia gravis: adverse effect of trihexyphenidyl on neuromuscular transmission.
    Ueno S; Takahashi M; Kajiyama K; Okahisa N; Hazama T; Yorifuji S; Tarui S
    Neurology; 1987 May; 37(5):832-3. PubMed ID: 3033545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dibutyryl cyclic AMP on neuromuscular transmission in myasthenia gravis.
    Hashimoto Y; Sasaki H; Iwatsuki K
    Tohoku J Exp Med; 1976 Oct; 120(2):197-8. PubMed ID: 185750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of action of muscle relaxants and its clinical problems].
    Suzuki H
    Masui; 1974 Aug; 23(8):679-92. PubMed ID: 4372420
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antibiotics and myasthenia gravis].
    Igata A
    Shinkei Kenkyu No Shimpo; 1971; 15(4):910-3. PubMed ID: 5168643
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical and pharmacological examination of neuromuscular transmission].
    Defféminis Rospide HA; Scarabino R; Silva Gaudin E
    Acta Neurol Latinoam; 1969; 15(1):117-26. PubMed ID: 4329847
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute effects of verapamil on neuromuscular transmission in patients with myasthenia gravis.
    Lee SC; Ho ST
    Proc Natl Sci Counc Repub China B; 1987 Jul; 11(3):307-12. PubMed ID: 2827211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.